Licensing Out

Licensing out of our continuously growing pool of readily available licensing-opportunities.

Outward and inward licensing of pharmaceuticals and technologies is an essential part of our activities. Our development effort, focussed on value-added and low-cost drugs and technologies, results in a portfolio of generics, value-added OTC formulations, biotech and prodrugs.

Our licensing portfolio contains a range of product-dossiers in several stages of regulatory approval, drugs in development and technology fine-tuning:
· Marketing Authorizations
· EU Registration Dossiers
· Development Projects of generics, supergenerics, biotech products, prodrugs
· Formulation technologies

In addition we offer the following business development services: drug registration in Europe (regulatory affairs), product development and product research, along with strategic regulatory planning and market-info.